![]() |
市场调查报告书
商品编码
1863649
全球医用电池市场:按类型、电池类型、应用、最终用户和地区划分 - 市场规模、行业趋势、机会分析和预测(2025-2033 年)Global Medical Battery Market: By Type, Battery Type, Application, End Users, Region - Market Size, Industry Dynamics, Opportunity Analysis and Forecast for 2025-2033 |
||||||
医用电池市场是整个医疗保健产业中至关重要且快速成长的区隔市场。 2024 年,该市场规模约为 18.976 亿美元,预计将实现显着增长,到 2033 年达到 31.4657 亿美元。预计 2025 年至 2033 年的复合年增长率 (CAGR) 为 5.78%。这一增长反映了可靠电源对于支援现代患者护理中必不可少的各种医疗设备的重要性日益增加。
医疗器材技术的进步进一步推动了医用电池市场的成长。创新正在催生更紧凑、更有效率、更精密的医疗器械,从而提升其功能并改善患者预后。随着这些设备变得越来越小巧、越来越精密,对能够在不影响安全性和可靠性的前提下为复杂电子设备供电的高密度电池的需求日益增长。医用电池必须符合严格的监管和安全标准,以确保在关键医疗环境中可靠运行,这使得医用电池的研发和生产成为医疗技术领域的专业且至关重要环节。
全球医用电池市场竞争异常激烈,前六名的公司(松下电器产业株式会社、Saft集团、GE医疗集团、Integer控股公司、金霸王电池和Maxell有限公司)占了超过45%的总收入。这些公司凭藉着丰富的产品组合、技术创新和策略合作伙伴关係,奠定了坚实的基础,成为各种医疗应用电池供应领域的领导者。
2025年10月,瓦尔塔股份公司在助听器行业领先的盛会-2025年欧洲助听器展(EUHA 2025)上展出了一系列用于助听器和其他医疗应用的一次性电池和可充电电池。瓦尔塔的产品线涵盖从标准电池到为特定医疗设备需求量身开发的专业解决方案。
2025年8月,一项重大进展发生:伊利卡公司(Ilika PLC)在美国马萨诸塞州的合作工厂完成了最终认证阶段,并开始生产固态微型电池。固态电池技术代表着一项重大进步,与传统的锂离子电池相比,它具有更高的安全性、更高的能量密度和更长的使用寿命等优势。
除了产业进步之外,学术研究也在推动医疗电池技术的创新。 2025年7月,英国南威尔斯大学(USW)的研究人员宣布计画开发可生物降解的电池,用于植入人体。这种电池采用可拉伸的超薄设计,能够自然地随人体移动,且不会造成不适或损伤。
核心成长因子
人工智慧 (AI) 与便携式诊断设备的整合显着提升了医疗电池市场对高性能电池的需求。这些先进设备利用复杂的演算法进行即时分析,即使在传统临床环境之外也能实现快速且准确的诊断。为了支援如此复杂的计算过程,这些设备需要高能量密度和持续可靠输出的电源。随着人工智慧驱动的医疗技术在医疗保健领域日益普及和重要,对满足这些严格要求的电池的需求正在迅速增长。
新机会趋势
得益于可摄入式电子设备及其高度微型化电源的显着进步,体内诊断的尖端技术正在快速发展。这些创新的 "智慧药丸" 代表了医疗技术的变革性飞跃,能够对人体内部功能进行非侵入性、即时监测。而其运作的核心在于必须符合严格标准的电池。为了适应这些设备的紧凑外形,电池不仅必须极其小巧,而且必须极其安全可靠。此外,它们必须提供足够的电力来运行复杂的感测机制和无线传输系统,同时保持最小的体积,以确保患者的舒适度和设备的有效性。
优化障碍
超级工厂(即大型电池製造设施)的建设延误可能会阻碍医疗电池市场的成长。这些超级工厂对于满足快速增长的高性能电池需求至关重要,尤其是锂离子电池,它们为各种医疗设备提供动力。这些设施的开发延误或停滞可能会在供应链中造成瓶颈,限制现有和新兴医疗技术所需电池的供应。由于建造超级工厂需要大规模和复杂的技术,延误通常源自于复杂的物流、财务和监管方面的挑战。
The medical battery market represents a crucial and rapidly expanding segment within the broader healthcare industry. Valued at approximately US$ 1,897.60 million in 2024, this market is projected to grow significantly, reaching an estimated valuation of US$ 3,146.57 million by 2033. This anticipated growth corresponds to a compound annual growth rate (CAGR) of 5.78% over the forecast period from 2025 to 2033. Such expansion reflects the increasing importance of reliable power sources in supporting a wide array of medical devices that are essential for modern patient care.
Technological advancements in medical devices further fuel the growth of the medical battery market. Innovations have led to more compact, efficient, and sophisticated devices capable of delivering enhanced functionality and improved patient outcomes. As these devices become smaller and more feature-rich, the need for high-density batteries capable of powering complex electronics without compromising safety or reliability has intensified. Medical batteries must meet stringent regulatory and safety standards to ensure they perform reliably in critical healthcare settings, making their development and production a specialized and essential sector within healthcare technology.
The global medical battery market is characterized by intense competition, with the top six players-Panasonic Corporation, Saft Group, GE Healthcare, Integer Holdings Corporation, Duracell, and Maxell Ltd-collectively accounting for more than 45% of the total revenue share. These companies have established strong footholds through extensive product portfolios, technological innovation, and strategic partnerships, positioning themselves as leaders in supplying batteries for a range of medical applications.
In October 2025, Varta AG showcased its extensive portfolio of primary and rechargeable batteries for hearing aids and other medical applications at EUHA 2025, a leading event in the hearing aid industry. Varta's offerings span from standard battery cells to highly specialized, individually developed solutions tailored to specific medical device needs.
In a significant development in August 2025, Ilika PLC commenced production of its solid-state micro-batteries in the United States after completing the final qualification stage at a partner facility in Massachusetts. Solid-state battery technology represents a major step forward, offering advantages such as increased safety, higher energy density, and longer lifespan compared to traditional lithium-ion batteries.
In addition to industry advancements, academic research is also driving innovation in medical battery technology. In July 2025, researchers at the University of South Wales (USW) in the UK announced plans to develop biodegradable batteries designed specifically for implantation in the human body. These batteries are engineered to be stretchable and ultra-thin, enabling them to move naturally with the body's movements without causing discomfort or damage.
Core Growth Drivers
The integration of artificial intelligence (AI) into portable diagnostic tools is driving a notable surge in demand for high-performance batteries within the medical battery market. These advanced devices rely on sophisticated algorithms to conduct real-time analysis, enabling faster and more accurate diagnostics outside traditional clinical settings. To support such complex computational tasks, these tools require power sources that combine high energy density with the ability to deliver sustained, reliable output. The demand for batteries that can meet these rigorous requirements is rapidly increasing as AI-enabled medical technologies become more widespread and essential in healthcare.
Emerging Opportunity Trends
The frontier of internal diagnostics is rapidly evolving, propelled by significant advancements in ingestible electronics and the increasingly sophisticated miniaturized power sources that support them. These innovative "smart pills" represent a transformative leap in medical technology, enabling non-invasive, real-time monitoring of internal bodily functions. Central to their operation are batteries that must meet exacting standards-not only must they be incredibly small to fit within the compact form factors of these devices, but they also need to be exceptionally safe and reliable. Additionally, these batteries must supply sufficient power to run complex sensing mechanisms and wireless transmission systems, all while maintaining a minimal footprint to ensure patient comfort and device efficacy.
Barriers to Optimization
Delays in the construction of gigafactories, which are large-scale battery manufacturing facilities, have the potential to hamper the growth of the medical battery market. These gigafactories are critical to meeting the rapidly increasing demand for high-performance batteries, particularly lithium-ion batteries that power a wide range of medical devices. When the development of such facilities is postponed or slowed, it creates bottlenecks in the supply chain that can restrict the availability of batteries necessary for both existing and emerging medical technologies. The scale and sophistication required for gigafactory construction mean that any delays often result from complex logistical, financial, and regulatory challenges.
By Battery Type, the lithium-ion battery segment holds a commanding position in the medical battery market, capturing an impressive 50.73% share. This dominance is fundamentally driven by the superior technological attributes that lithium-ion batteries offer compared to other battery types. One of the most critical advantages is their high energy density, which typically ranges between 150 and 250 watt-hours per kilogram (Wh/kg). This high energy density enables medical device manufacturers to design smaller, more compact, and lightweight products without compromising on battery life or performance. In medical applications, where device portability and patient comfort are paramount, the ability to reduce size and weight while maintaining power capacity is a significant benefit.
By Type, the non-implantable medical devices battery segment commands the largest share in the medical battery market, accounting for 56.60% of the total. This leading position is largely due to the vast volume and diverse range of portable and wearable medical devices that rely on battery power in today's healthcare landscape. Unlike implantable devices, non-implantable medical devices encompass a broad spectrum of equipment used in hospitals, clinics, and increasingly in home and remote care settings. Their widespread adoption across multiple healthcare environments drives substantial demand for reliable, high-performance batteries.
By Application, the implantable medical devices segment exhibits remarkable market strength, commanding the largest share of 46.33% within the medical battery market. This dominant position is closely tied to the critical and life-sustaining functions that implantable devices perform, which in turn impose exceptionally stringent requirements on their power sources. Because these devices operate inside the human body, their batteries must deliver reliable, long-lasting energy to ensure continuous functionality without frequent interventions, making battery performance a matter of patient safety and quality of life.
By End Users, the hospitals and clinics segment commands the largest, accounting for an impressive 49.07%. This substantial share is primarily attributed to the high concentration of battery-powered equipment utilized within these healthcare facilities. Hospitals and clinics are critical environments where reliability and performance of medical devices are essential, and the prevalence of mobile and portable devices underscores their dependence on efficient battery solutions.
By Type
By Battery Type
By Application
By End User
By Region
Geography Breakdown